← Back to Search

PFIcope+EMI for Alcoholism

N/A

Recruiting

Led By Ana M Abrantes, Ph.D.

Research Sponsored by Butler Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Current anxiety and/or depression symptomatology (as assessed by CES-D scores above cut-off for high risk for clinical depression and GAD-7 scores above cut-off for moderate to severe anxiety)

Between 18 and 25 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6-month follow-up

Awards & highlights

Study Summary

This trial will test if an intervention combining personalized feedback and text messaging can reduce drinking to cope, alcohol use, and negative affect in young adults.

Who is the study for?

This trial is for young adults aged 18-25 who drink alcohol heavily at least three times a week and use it to cope with negative feelings. They must have symptoms of anxiety or depression, own a smartphone, but not be currently suicidal or have severe substance use disorders (except for alcohol, cannabis, or nicotine) or psychotic conditions.Check my eligibility

What is being tested?

The study tests an intervention combining personalized feedback on drinking habits with real-time support through text messages against just receiving personalized feedback. The goal is to see if this approach can reduce the need to drink due to stress and overall alcohol consumption over six weeks.See study design

What are the potential side effects?

Since this trial involves behavioral interventions rather than medications, traditional side effects are not expected. However, participants may experience discomfort discussing personal habits or receive distressing feedback about their drinking patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently experiencing significant symptoms of anxiety and/or depression.

Select...

I am between 18 and 25 years old.

Select...

I drink alcohol 3 times a week and binge drink at least once a week.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Other outcome measures

Alcohol Outcome Expectancies

Alcohol-related problems

Drinking Motives

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PFIcope+EMIExperimental Treatment1 Intervention

The 6-week PFIcope+EMI includes: 1) an in-person personalized feedback session to present feedback on problems with drinking to cope, discuss the individual's use of alcohol to cope, and generate coping skills messages to be used in the EMI intervention; 2) EMA to monitor affect, intention to drink, coping skills usage, alcohol use, drinking to cope post-discharge; 3) tailored text messages (EMI) based on EMA (individualized coping skills messages when NA and intention to drink are reported).

Group II: PNFActive Control1 Intervention

Participants in the PNF condition will receive normative feedback only on their alcohol use.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Butler HospitalLead Sponsor

129 Previous Clinical Trials

16,358 Total Patients Enrolled

4 Trials studying Alcoholism

429 Patients Enrolled for Alcoholism

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH

801 Previous Clinical Trials

1,365,337 Total Patients Enrolled

423 Trials studying Alcoholism

985,648 Patients Enrolled for Alcoholism

Ana M Abrantes, Ph.D.Principal InvestigatorButler Hospital/Alpert Medical School of Brown University

3 Previous Clinical Trials

199 Total Patients Enrolled

Media Library

Coping-Motive Specific Personalized Feedback Intervention plus an Ecological Momentary Intervention (PFIcope+EMI) Clinical Trial Eligibility Overview. Trial Name: NCT05074030 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this medical study open to participants aged 65 and above?

"The eligibility requirements for this experiment dictate that participants should be aged between 18 and 25. There are also 20 additional trials intended to recruit minors, while 199 other studies seek elderly volunteers."

Answered by AI

Does this clinical experiment have any vacancies for participants?

"According to the data hosted on clinicaltrials.gov, it appears that this medical study is not actively recruiting participants at present. The research was first posted on October 1st 2022 and last updated August 10th of the same year. However, there are 268 other trials currently searching for patients in need of a treatment option."

Answered by AI

What criteria must I meet to be accepted as a participant in this trial?

"To be eligible for this trial, participants must have a diagnosis of alcohol addiction and fall between the ages 18 to 25. The research team is currently recruiting 60 individuals."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

EMA/EMI for Psychiatrically Hospitalized Emerging Adults Who Drink to Cope

2023. "EMA/EMI for Psychiatrically Hospitalized Emerging Adults Who Drink to Cope". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05074030.

All > Alcoholism